Home > Quotes > AMGN

Amgen Inc. Common Stock Quote & Summary Data

Get AMGN Alerts
*Delayed - data as of May 3, 2016  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    AMGN After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Amgen Inc. Common Stock Intraday Chart

News for AMGN

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 158.4599 $ 181.81
Low $ 156 $ 130.09

The current last sale of $156.35 is 20.19% Higher thanthe 52 week low.

P/E Ratio

ETFs with AMGN as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
12.2% VanEck Vectors Biotech ETF (BBH) -14.33 (-11.78%)
8.72% iShares Nasdaq Biotechnology Index Fund (IBB) -53.34 (-16.45%)
5.74% PowerShares Dynamic Biotech &Genome (PBE) -9.29 (-18.92%)
5.15% PowerShares Dynamic Pharmaceuticals (PJP) -9.86 (-13.62%)
4.49% SPDR Select Sector Fund - Health Care (XLV) -1.19 (-1.67%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Amgen Inc. (including its subsidiaries, referred to as "Amgen," "the Company," "we," "our" or "us") is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987.  ... More ...  

Risk Grade

Where does AMGN fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?